O=c1c(Cc2ccc(Cl)cc2)nnc2sc(-c3ccc(-c4ccc(F)c(Cl)c4)o3)nn12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?